Tomorrow's Health, Today's Research

Dr. Caroline Cameron

Associate Professor, Biochemistry/Microbiology Department
Canada Research Chair in Molecular Pathogenesis
This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
This e-mail address is being protected from spam bots, you need JavaScript enabled to Phone: (250) 853-3189
Department Page
Research area: host-bacteria interactions, spirochetes, syphilis and leptospirosis
______________________________________________________________________________

Research profile:

Syphilis expertise leads to whale research

One of the downsides of being a molecular biologist is that it’s hard to get out of the lab. Not for Dr. Caroline Cameron, whose interest in syphilis has led her down an unlikely path to marine biology. While she still primarily researches syphilis, her field work has ranged from catching snot from whales to clambering over seashores (while six-months pregnant no less) in Washington state to help veterinarians take blubber samples from sick seals.

The connection between her projects is a phylum of bacteria called spirochetes, so called because of their spiral shape.

Cameron first became interested in spirochetes when she went to the University of Washington, following her PhD at UVic, to help with a new syphilis research project. Now as an Associate Professor with the biochemistry/microbiology department and as a Canada Research Chair in Molecular Pathogenesis, she is the only researcher in Canada performing basic research on this difficult disease.

She was attracted to syphilis because of its history and its persistence. Syphilis should have been eliminated in the same way as small pox, explains Cameron.

“It is so easily treated early in the disease – just one dose of penicillin,” she says.

Yet there has been a resurgence of syphilis starting with a sharp rise in 1997. Since then cases have continued to rise in localized outbreaks across Canada, including an outbreak in Vancouver’s downtown eastside.

The later stage of syphilis infects every organ of the body including the brain (thus the association of syphilis with insanity). Worse, infection with syphilis greatly increases your chance of getting HIV.

In fact, one source of funds for Cameron’s work is a Canadian Institutes of Health Research grant for HIV prevention. In that project, Cameron is developing a better test to diagnose syphilis. Several current methods for diagnosing syphilis are based on detecting antibodies in patient’s blood against Treponema pallidum, the spirochete that causes the STD. But these tests are poor at detecting early infections when the risk for contracting HIV is highest.

Cameron and her colleagues at the University of Washington have patented a test based on a cocktail of three antigens (the portion of a protein the immune system recognizes) that are better targets to detect. She is currently using recombinant DNA techniques to combine the antigens into one protein to facilitate its production.

Another coup for Cameron is the model system to study T. pallidum she developed in collaboration with her colleague at the State University of New York at Buffalo. One of the reasons T. pallidum is so neglected by researchers is that it will not grow outside an animal host, making it devilishly tricky to study. Cameron clones proteins of interest into a related Treponema species that can be grown in the lab.

She also is working with her collaborator at the Vrije Universiteit Medical Center in Amsterdam to identify T. pallidum proteins that bind to sugars using carbohydrate arrays. These proteins are likely to be important in helping the bacteria bind to human cells and spread. Her ultimate goal is to find new drugs, or better yet, a vaccine.

Meanwhile her expanding molecular expertise leant itself very neatly to an interesting spirochete that is unusual because it can infect virtually any animal, including humans: Leptospira, which causes leptospirosis. Leptospirosis is best known as a disease of dogs, but it may play a part in the mysterious deaths of hundreds of sea lions that wash up along the West Coast about once every seven years.

Cameron works closely with marine biologists, veterinarians and PhD scientists throughout North America in a project to figure out how the disease spreads through marine mammal populations. She recently submitted a paper on a Polymerase Chain Reaction (PCR) diagnostic method that should help. Her test can detect the disease in symptom-free animals that may be spreading leptospirosis and wouldn’t otherwise be diagnosed.

The test is also useful to diagnose leptospirosis in decomposed carcasses or from feces and urine on the beach. In another project she is using proteomic techniques to compare proteins found in virulent strains of Leptospira to proteins in harmless strains to decipher what makes some strains nasty.

Now the non-profit group Global Research and Rescue is conducting a project in the San Juan Islands to monitor the health of resident Orcas. Cameron is assisting with collecting samples to determining the pathogen repertoire of the sea water and whales.

Cameron loves how her research on spirochetes has provided her with the chance to get on the ocean next to whales - not part of a typical task for a molecular biologist. It makes one wonder what she’ll do next.

The leg bone is connected to the arm bone

How does the nervous system coordinate the arms and legs during walking? Professor Dr. E. Paul Zehr has expanded the focus of neuroscientists studying motor control, leading to new treatments for stroke victims. More

Poxvirus expert creates bioinformatics tools

Dr. Chris Upton bridges gap between genetics and computers with the Viral Bioinformatics Resource Center. More

An eye for detail

Dr. Jim Tanaka, a cognitive neuroscientist, is examining whether autistic children can be taught to overcome "face blindness" by engaging a part of their brains, which they use to expertly recognize other objects. More

A new way to look for cancer biomarkers

Dr. Terry Pearson is banking on mass spectrometry to be the next big thing for antibody-based diagnosis. More

Elegant strategy works against broad range of cancers

Dr. Brad Nelson thinks the time is right for T cell therapy. More

Why nicotine is addictive, yet good for the brain

Neuroscientist Dr. Raad Nashmi found a new pathway for nicotine addiction, which also helps explain nicotine’s benefits for those prone to Parkinson’s. More

Tracking genetic disorders

Whether he is finding a genetic cure or tracking a rare mutation, Dr. Patrick Macleod is a vital link between patients and molecular researchers at the CBR. More

 

Bringing the power of genomics to aquaculture

Dr. Ben Koop co-founded the consortium for Genomic Research on All Salmon Project (cGRASP), an international team devoted to understanding salmon from its DNA out: its evolutionary history, its ecology, its health. More

Speed up and lighten up

Neuroscientist Dr. Sandra Hundza explores ways to teach people to walk again after a neurotrauma like a stroke or spinal cord injury, based on understanding the neural patterns that control rhythmic movement

Listening to cells talk

The field of signal transduction is fulfilling its early promise of cancer cures. Professor Dr. Perry Howard is looking for signals to kill cancer cells. More

Learning, Dopamine and ADHD

Subheadline for CBR front page flash: Cognitive neuroscientist Dr. Clay Holroyd is rephrasing the symptom of “inability to focus” to “an inability to get the appropriate dopamine reward for focus.” More

The promise of synthetic molecules for controlling proteins

If you can’t find the right chemical tool to suit your medical research, you could ask chemist Dr. Fraser Hof to build one. Histone experts eye up Hof’s latest: a synthetic molecule that binds histones, disrupting a gene regulation pathway. More

A better way to test for pollutants

Forty years after Rachel Carson wrote Silent Spring, Dr. Caren Helbing’s work warns us that we still don’t really know how to test for chemical contaminants in the environment. More

CBR founder tackles risks and ethics

Dr. Barry Glickman helps Health Canada and the Canadian Space Agency sort through the hype to find the real potential — and threats — of nanotechnology. More

Order in the chaos

Dr. Roderick Edwards finds patterns invisible to the naked eye, as he seeks for order in systems as complex as neuronal nets. More

Salmon genome gives clues to evolution

Dr. Johan de Boer describes how a salmon ancestor diverged so quickly into dozens of species thanks to transposons. More
 

Exercise reverses fetal alcohol syndrome (FAS)

Dr. Brian Christie was one of the first neuroscientists to discover that exercise promotes the generation of new brain cells. In his latest research, he found that exercise can even reverse FAS-related brain damage. More

The heartbreak of tracking rare mutations

Dr. Francis Choy's study of inherited diseases has immediate impact on patients. More

Watching eyes grow

Dr. Robert Chow is finding genes that control eye development. More

Syphilis expertise leads to whale research

When Dr. Caroline Cameron is not studying syphilis, she’s catching snot from whales: the strange path from syphilis to marine biology. More

Sea urchin sequence accelerates discoveries

Dr. Robert Burke has seen developmental biology grow up and zoom in. When he helped finish the sea urchin sequence in 2006, the field took another quantum leap forward. More

Deciphering the Histone Code

Dr. Juan Ausio helped figure out the structure and nature of chromatin, which led to the idea of a histone code. More